Table 3.
Risk factors, N (%) | Univariate analysis | Multivariate analysis | Multivariate analysis p value |
---|---|---|---|
Age > 62 years | 1.1 (0.9 – 1.3) | not included | |
Gender Male | 1.1 (0.9 – 1.4) | not included | |
Histology type of primary tumor | |||
Adenocarcinoma | Comparator | ||
Large cell carcinoma | 1.3 (0.8 – 2.2) | ||
Squamous cell carcinoma | 1.3 (1.0 – 1.6) | ||
Small cell lung cancer | 2.3 (1.7 – 3.2)* | 2.0 (1.5 – 2.8) | <0.001 |
Stages of cancer | |||
Ia/Ib | comparator | ||
IIa/IIb | 1.6 (0.8 – 3.2) | 2.5 (1.4 – 4.6) | 0.002 |
IIIa/IIIb | 2.7 (1.6 – 4.7)* | 3.0 (1.7 – 5.4) | <0.001 |
IV | 3.7 (2.2 – 6.2)* | - | ns |
Extensive | 3.9 (2.2 – 6.9)* | - | ns |
Limited | 2.7 (1.3 – 5.6)* | - | ns |
No surgical treatment for lung cancer | comparator | ||
Surgical treatment for lung cancer | 0.4 (0.3 – 0.6)* | 0.6 (0.4 – 0.9) | 0.005 |
Time from PH to DX > 3 months | 1.0 (0.8 – 1.2) | not included | |
Time from first app to DX > 2 months | 1.2 (1.0 – 1.5) | not included | |
Time from DX to TTO < 1.5 months | 1.8 (1.4 – 2.2)* | 2.1 (1.6 – 2.6) | <0.001 |
p value <0.05 (univariate analysis by Cox regression).